Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

被引:42
|
作者
Nasreen, Najmunnisa [1 ]
Mohammed, Kamal A. [1 ]
Lai, Yimu [1 ]
Antony, Veena B. [1 ]
机构
[1] Univ Florida, Dept Med, Div Pulm & Crit Care Med, Gainesville, FL 32611 USA
关键词
EphA2; EphrinA1; malignant mesothelioma; receptor tyrosine kinase; proliferation; ERK1/2;
D O I
10.1016/j.canlet.2007.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of this study was to understand the possible mechanisms of activation of receptor EphA2 by its ligand ephrinA1 in malignant mesothelioma cell (MMC) growth. Activation of receptor EphA2 by its ligand ephrinA1 triggered the phosphorylation of EphA2. Ligand activation of EphA2 also induced phosphorylation of ERK1/2 and significantly decreased MMC proliferation. Ligand activated and ephrinA1 vector (pcDNA/EFNA1) transfected MMC demonstrated decreased clonal growth in 3-D matrigels when compared to resting MMC. These studies suggest that EphA2 activation by its ligand ephrinA1 transmits intracellular signals from cell membrane to nucleus via ERK1/2 signaling cascade and inhibits MM growth. Published by Elsevier Ireland Ltd.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 50 条
  • [21] Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury
    Hong, Ji Young
    Shin, Mi Hwa
    Douglas, Ivor S.
    Chung, Kyung Soo
    Kim, Eun Young
    Jung, Ji Ye
    Kang, Young Ae
    Kim, Se Kyu
    Chang, Joon
    Kim, Young Sam
    Park, Moo Suk
    CLINICAL SCIENCE, 2016, 130 (21) : 1993 - 2003
  • [22] Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma
    Mohammed, Kamal A.
    Wang, Xiaohong
    Goldberg, Eugene P.
    Antony, Veena B.
    Nasreen, Najmunnisa
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (03): : 419 - 431
  • [23] EphA2/EphrinA1 mRNA Expression and Protein Production in Adenoid Cystic Carcinoma of Salivary Gland
    Shao, Zhe
    Zhu, Fei
    Song, Kai
    Zhang, HanZhong
    Liu, Ke
    Shang, ZhengJun
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 71 (05) : 869 - 878
  • [24] EphA2/ephrinA1 system may regulate invadopodia formation of glioblastoma multiforme (GBM) cells
    Gonzalez, Oscar A.
    Seals, Darren
    Debinski, Waldemar
    CANCER RESEARCH, 2011, 71
  • [25] Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma
    Li, Xia
    Wang, Li
    Gu, Jian-Wen
    Li, Bing
    Liu, Wei-Ping
    Wang, Yan-Gang
    Zhang, Xiang
    Zhen, Hai-Ning
    Fei, Zhou
    TUMOR BIOLOGY, 2010, 31 (05) : 477 - 488
  • [26] Defective Trafficking of Senescent Human Cardiac Stem Cells: Role of EphrinA1/EphA2 Interaction.
    Bai, Yingnan
    Goichberg, Polina
    Rota, Marcello
    Rayatzadeh, Hussein
    Ferreira-Martins, Joao
    D'Amario, Domenico
    Fiorini, Claudia
    Hosoda, Toru
    Zheng, Hanqiao
    Urbanek, Konrad A.
    del Monte, Federica
    Sylvin, Erik
    D'Alessandro, David A.
    Michler, Robert E.
    Anversa, Piero
    Kajstura, Jan
    Bolli, Roberto
    Leri, Annarosa
    CIRCULATION, 2010, 122 (21)
  • [27] 食管鳞状细胞癌组织中EphA2和EphrinA1的表达
    徐峰
    李娅
    袁丽
    李继昌
    索振河
    Jahn MNesland
    郑州大学学报(医学版), 2008, (03) : 421 - 425
  • [28] EPHA2/EPHRINA1 SYSTEM IN CONJUNCTION WITH TKS5 REGULATES INVADOPODIA FORMATION IN GLIOBLASTOMA CELLS
    Debinski, Waldemar
    Gonzales, Oscar
    Beauchamp, Amanda
    Gibo, Denise M.
    Seals, Darren F.
    NEURO-ONCOLOGY, 2012, 14 : 14 - 14
  • [29] Spatial Organization of EphA2 at the Cell-Cell Interface Modulates Trans-Endocytosis of EphrinA1
    Greene, Adrienne C.
    Lord, Samuel J.
    Tian, Aiwei
    Rhodes, Christopher
    Kai, Hiroyuki
    Groves, Jay T.
    BIOPHYSICAL JOURNAL, 2014, 106 (10) : 2196 - 2205
  • [30] EphrinA1/EphA2 Promotes Epithelial Hyperpermeability Involving in Lipopolysaccharide-induced Intestinal Barrier Dysfunction
    Chen, Yuhua
    Zhang, Lei
    Zhang, Yongbo
    Bai, Tao
    Song, Jun
    Qian, Wei
    Hou, Xiaohua
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 26 (03) : 397 - 409